Candida albicans is the most common cause of serious fungal disease in humans. Creation of isogenic null mutants of this diploid organism, which requires sequential gene targeting, allows dissection of virulence mechanisms. Published analyses of such mutants show a near-perfect correlation between C. albicans pathogenicity and the ability to undergo a yeast-to-hypha morphological switch in vitro. However, most studies have used mutants constructed with a marker that is itself a virulence determinant and therefore complicates their interpretation. Using alternative markers, we created ~3,000 homozygous deletion strains affecting 674 genes, or roughly 11% of the C. albicans genome. Screening for infectivity in a mouse model and for morphological switching and cell proliferation in vitro, we identified 115 infectivity-attenuated mutants, of which nearly half demonstrated normal morphological switching and proliferation. Analysis of such mutants revealed that virulence requires the glycolipid glucosylceramide. To our knowledge, this is the first C. albicans small molecule that has been found to be required specifically for virulence.
A r t i c l e s C. albicans is the major cause of serious fungal infections in the United States, and Candida species are the fourth most commonly cultured microbe from blood 1 . Whereas some human fungal pathogens exist pri marily as budding yeast cells (for example, Cryptocococcus neoformans) or filamentous hyphal structures (for example, Aspergillus spp.), C. albicans belongs to a group that freely alternates between these and other morpho logies in response to specific environmental cues. Unlike other major fungal pathogens, C. albicans composes part of the normal human microbiome, inhabiting the skin and gastrointestinal tract as a commensal organism. However, it also produces serious disease in people who have immune deficits, who have undergone surgical instrumentation or who have been treated with long courses of antibiotics. The attributable mortality from bloodstream C. albicans infections in adults is at least 15% (ref. 2) . Despite the frequency and seriousness of these infections, there are few tests and antifungal drugs to diagnose and treat them.
C. albicans has an obligate diploid genome and lacks a complete sexual cycle, two properties that have historically hindered genetic approaches to studying this organism. Nonetheless, numerous genes important for virulence have been identified through 'reverse genetics' , in which both alleles of a selected gene are inactivated and the resulting mutant evaluated for ability to cause disease. These studies have found a strong correlation between virulence and the ability to alternate among three morphological forms-yeasts, hyphae and pseudohyphae ( Fig. 1a and Supplementary Table 1; ref. 3). Because the morphological switch is itself a complex transition involving changes in cellular shape, mechanical properties, interactions with other cells and differential expression of myriad genes [4] [5] [6] [7] , its close association with virulence has made it difficult to dissect out specific virulence mechanisms and effectors. Indeed, it remains uncertain whether the observed virulence defects result from defects in morpho logy per se or from genes whose expression is correlated with a par ticular morphological state 8 .
A second factor complicating the understanding of C. albicans virulence is the use of URA3 as a selectable marker in the majority of published mutants. Several studies have established that adequate expression of URA3 is essential for normal virulence as well as for efficient transitions between yeast and filamentous forms [9] [10] [11] [12] [13] . Because URA3 has been used to replace the target gene of most published mutants and because its expression can vary substantially as a func tion of chromosomal position [9] [10] [11] , rigorous interpretation of pub lished mutants has often proven difficult.
To investigate C. albicans virulence afresh, we created a large number of homozygous gene disruption mutants using auxotrophic markers that are neutral for virulence 14 (Fig. 1b) . Because many C. albicans laboratory strains are aneuploid 15, 16 , we verified that the parental strain SN152 had a diploid chromosome number by contour clamped homogeneous electric field gel analysis 14 and comparative genome hybridization 17 . Gene targets were selected to represent a wide variety of cellular processes, and the majority were previously unstudied. We barcoded each mutant by embedding one of 48 unique oligonucleotide sequences in the gene disruption cassette. Rigorous quality control was implemented to verify deletion of both target alleles, as well as the absence of a third copy of the ORF. To control for unwanted genetic rearrangements that sometimes arise during Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity A r t i c l e s mutant construction in C. albicans 17, 18 , two or more independent isolates were derived for each targeted gene. In total, we constructed ~3,000 strains that correspond to deletions of 674 ORFs, or ~11% of annotated coding genes in the C. albicans genome.
Three phenotypes that have been associated with virulence in animal models-infectivity in a mouse model of disseminated candidiasis, the yeasttohypha transition in vitro and proliferation rates in vitro-were monitored across the entire deletion collection. Contrary to expectation, these traits were not strictly correlated with each other. In particular, many infectivitydefective mutants had normal morphological transitions and proliferation in vitro. We hypothesized that, unlike mutants with associated defects in morphogenesis and proliferation, those with isolated infectivity defects could be used to define discrete effectors of pathogenesis. We therefore pursued four such mutants with directed biochemical and virulence experiments, resulting in the identification of a biosynthetic pathway for glucosyl ceramide as a novel virulence factor that is important in the mouse, but dispensable for morphogenesis and proliferation in vitro. To our knowledge, glucosylceramide is the first small molecule synthesized by C. albicans to be found to have these characteristics.
RESULTS

Constructing a high-quality C. albicans gene deletion library
We designed our knockout library to include genes involved in a broad spectrum of cellular processes and to avoid a strong bias toward factors already known to affect C. albicans virulence. When this work was begun, the genome of clinical strain SC5314 had been sequenced and partially assembled by the Stanford Genome Technology Center 19 We created a database that assembled the putative ORFs with results of pairwise BLAST comparisons to multiple sequenced genomes and predicted functional motifs (using the SMART algorithm). We next compiled the following nonexclusive sets of target genes: (i) genes without clear homologs in two nonpathogenic yeasts, Saccharomyces cerevisiae and Schizosaccharomyces pombe; (ii) genes apparently unique to C. albicans (not conserved in other sequenced genomes); (iii) genes with a functional motif potentially related to virulence (for example, all genes with signatures of cell surface proteins such as signal sequences and glycosylphosphatidylinositol anchors); and (iv) additional ORFs of interest (for example, genes whose transcripts are associated with the She3dependent RNA transport system 20 ) . After excluding candidates that appeared unlikely to encode proteins, those in transposons and those that were homologous to essential genes in S. cerevisiae, we identified 1,152 targets for disruption.
Mutants were constructed in C. albicans strain SN152, a derivative of SC5314 with auxotrophies for histidine, leucine and arginine 14 (Fig. 1b) . These nutritional markers are not required for virulence in the murine tail vein injection model that is most commonly used for virulence analysis 14 . Briefly, a fusion PCR technique was used to synthesize gene disruption cassettes containing either Candida dubliniensis HIS1 or Candida maltosa LEU2 flanked by ~350 nucleo tides matching sequences upstream and downstream of the target gene. One of 48 20nucleotide barcodes was included adjacent to the selectable markers. Heterozygous gene disruption strains were constructed by transformation of SN152 with a HIS1-marked gene disruption cassette; His + transformants were screened by colony PCR for the presence of expected 5′ and 3′ junctions of the integrated DNA. Homozygous gene disruption strains were constructed by transfor mation of the heterozygous knockout strain with a LEU2marked gene disruption cassette; His + Leu + transformants were screened for expected 5′ and 3′ junctions of the second disrupted allele and for absence of the original target ORF. At least two homozygous knockout isolates were obtained for each target gene.
We were successful in obtaining homozygous knockouts of 64% of target genes, based on the original ORF designations ( Fig. 1b) . Some of the failures undoubtedly corresponded to essential genes. In the current C. albicans genome annotation, the disruption mutantscomprising more than 3,000 strains-correspond to 674 unique genes. Below, we describe the characterization of these mutants by means of three genetic screens: an in vivo screen for infectivity, and in vitro screens for morphogenesis and rate of proliferation ( Fig. 1c ).
Infectivity screen identifies 115 candidate virulence factors
Classical virulence analysis of C. albicans mutants typically involves infecting groups of mice with an individual mutant or a wildtype strain and comparing the course of illness; virulencedefective mutants produce less disease or a delay in disease onset. To minimize the number of animals required to characterize our library of mutants, we adapted the signaturetagged mutagenesis technique, which has been highly successful in identifying novel virulence factors of bacterial A r t i c l e s pathogens [21] [22] [23] . The method involves simul taneous infection of an animal model with numerous mutants of interest, each marked by an oligonucleotide 'signature tag' that allows for individual quantification. Theoretically and in practice, mutants with virulence defects have reduced competitive fitness and are selectively depleted in the host. In the mouse model of disseminated candidiasis, kidneys are the organs of greatest fungal proliferation 24 , and kidney tissue burden has been highly correlated with virulence among published mutants 3 (see Supplementary Table 2 ). We used pools of 48 barcoded C. albicans mutants and a matched wildtype strain to infect BALB/c mice by tail vein injection ( Fig. 2a) . After disease had progressed, the mice were euthanized, and the abundance of C. albicans strains recovered from host kidneys (R) and the infecting inoculum (I) was determined by realtime PCR (using primers to the signature tags). Each mutant was evaluated in at least six mice, and at least two independent isolates of each mutant were assessed.
We screened a total of 118 pools, and the results-representing 6,917 realtime PCR measurements of C. albicans knockout mutants and 472 measurements of wildtype yeast-are presented in Figure 2b . The xaxis represents the log 2 ratio of the abundance of each strain in the recovered pool relative to the inoculum. A strain whose represen tation neither increased nor decreased in the infected mouse would have a ratio of 1, or a log 2 ratio of 0. A strain that became underrep resented over the course of infection would be shifted to the left, and one that accumulated would be shifted to the right. Inspection of the histogram of wildtype C. albicans, derived from data acquired from the majority of mice throughout the screen (blue bars), revealed a bellshaped distribution consistent with simple variation around a mean. In contrast, the distribution of the mutants (orange bars) was asymmetric, skewed to the left. We assumed that the prominence of the leftsided tail resulted from mutants with fitness defects in infect ing or proliferating in mouse kidneys; we hypothesized that many of these mutants would also be defective in causing disease. Mutants shifted to the right may have had a fitness advantage resulting in hyperproliferation or a defect, for example, in exiting the kidney.
Although many mutants showed obvious defects in infectivity (with log 2 (R/I) values shifted far to the left in Fig. 2b ), we used two sys tematic, statisticsbased tests to also capture mutants with moderate defects. This analysis, along with estimates of false discovery rates and our results with previously published virulence mutants, are described in detail in the Online Methods. Using these tests, we identified 115 mutants with substantial defects in infectivity ( Supplementary  Table 3 ). These mutations disrupt genes involved in a broad range of cellular processes; as might be expected, they also affect a sizeable group of genes whose functions are completely unknown. Pools of up to 48 mutants and the wild-type strain were used to infect BALB/c mice. Samples of C. albicans from the infecting inoculum and recovered from mouse kidneys were plated on Sabouraud agar. Genomic DNA was recovered, and the relative abundance of each strain in the inoculum and the recovered pool was determined by real-time PCR (qPCR) using primers specific to the DNA barcodes. (b) Histograms depicting log 2 (R/I) values for C. albicans mutants (orange), the wild-type comparator (blue) and the overlay between the two groups. Wild-type morphology is scored as 0, and aberrant morphology is scored from 1 to 3 (increased relative to wild type) and −1 to −3 (decreased relative to wild type) for both C and P scores. The morphology score (M score) of each mutant is calculated as the sum of the absolute values of C and P. (b) Schematic of the colony morphology screen. One isolate of each of the 674 mutants and the wild-type strain was initially plated for single colonies on Spider medium. Mutants showing morphology different from the wild type underwent testing of one to three additional isolates (depending on availability) to confirm consistency of the phenotype.
Morphogenesis screen reveals determinants of dimorphism
(c) Histogram of infectivity defects among mutants with different M scores. *Significant association with infectivity defect (using the hypergeometric distribution); P = 0.0077 for M score of 2, P = 4.8 × 10 −6 for M score of 3, P = 4.8 × 10 −6 for M score of 4, P = 0.10 for M score of 5, P = 0.027 for M score of 6. A r t i c l e s 'dimorphic' transition, this process actually involves interconversions among three types of cells: budding oval yeast cells that separate after cell division, and two types of elongated cells that remain attached as filaments, called hyphae and pseudohyphae 4, 25 . Interconversions among the three cell types are induced in vitro by modifying the pH, phosphate concentration, temperature or serum concentration in the growth medium, or a combination of these variables, which are thought to mimic environmental cues found within different niches of the host. The macroscopic appearance of a C. albicans colony derives from the types of the cells that make it up, and changes in colony morpho logy have been used as a sensitive indicator of mutants with defects in the dimorphic transition 26 . On a variety of media, wildtype C. albicans generates colonies with two distinct regions ( Fig. 3a) : a central region (C) consisting of yeast, pseudohyphae and true hyphae, and a peripheral region (P) consisting primarily of filamentous forms (hyphae and pseudohyphae). Mutants shifted toward filamentous forms produce colonies with increased central wrinkling or peripheral filamentation, or both; mutants shifted toward the yeast morphology produce smooth colonies with decreased peripheral filamentation.
We examined colony morphology across our mutant library. Five to ten cells of each mutant were plated on solid Spider medium and incubated at 30 °C ( Fig. 3b) . Colonies were photographed at 14 days, and central and peripheral regions were each assigned a score (C and P, respectively) on a scale of −3 (decreased morphology) to +3 (increased morphology), with 0 indicating wildtype morphology. The overall morphology score (M score) was the sum of the absolute values of C and P and ranged from 0 (wildtype) to 6 (highly aberrant). Mutants with M scores of other than 0 underwent testing of additional isolates to confirm the consistency of the phenotype. Ultimately, 504 mutants were indistinguishable from the wild type (M score of 0), 16 had mildly altered morphology (M score of 1) and 133 had substan tial aberrations (M score of 2 or greater; Table 1 ). Four mutants had inconsistent defects (different abnormal morphologies), most likely resulting from unlinked mutations in at least one of the isolates, and 17 mutants grew slowly on Spider medium; these were excluded from subsequent analysis. Mutants with substantial morphology defects (M score of 2 or more) are presented in Supplementary Table 4 , and data for all of the mutants are in Supplementary Table 5 .
We next examined the correlation between defects in infectivity and defects in the yeasttohypha transition by determining the frequency of infectivity defects among mutants with a given M score. If the abil ity to undergo the dimorphic transition were the major determinant of virulence, then the proportion of infectivitydefective mutants would be expected to increase as a function of the M score. This pre diction was only partially borne out by our data (Fig. 3c) . Mutants with an M score >0 were more likely to have infectivity defects than those with wildtype morphology (37% versus 10%; P = 6.5 × 10 −14 , calculated using the hypergeometric distri bution), in keeping with the prevailing view that morphogenesis and infectivity are asso ciated. However, among 24 mutants with the highest M scores of 5 and 6, twothirds showed normal infectivity. Likewise, among 103 infectivitydefective mutants that were scored for morphology, 48, or 47%, had nor mal colony morphology on Spider medium. These results demonstrate that the relation ship between infectivity and morphogenesis cannot be one of simple cause and effect. Although colony morphology is a sensitive indicator of mutants with defects in the dimorphic switch, we also employed a specific test of the ability of yeast cells to form hyphae. We tested the group of 115 infectivitydefective mutants for a hyphal response to serum, which is the 'germ tube test' used by clinical laboratories to distinguish C. albicans from other yeasts. Only 15 mutants did not elaborate true hyphae ( Supplementary Table 6 ), all of which were also captured by the colony morphology assay (n = 12) or grew too slowly on this medium to be scored (n = 3).
Proliferation screen identifies mutants with slow growth
It is a reasonable assumption, and one often made in the literature 27 , that a C. albicans mutant showing slow proliferation in vitro will have a corresponding virulence defect in vivo. We addressed this assump tion systematically by measuring proliferation rates across the mutant library and comparing them with the infectivity data. Wildtype C. albicans and two isolates of each mutant were grown in chemically defined liquid medium at 37 °C, and doubling times were measured (Supplementary Table 5 ). The median doubling time of wildtype yeast under these conditions was 87 min.
Sixtyeight mutants had significant defects in proliferation, defined as a doubling time more than two s.d. greater than that of the wild type ( Table 1) . Contrary to our expectations, the majority (42, or 62%) of these proliferationdefective mutants were competent for infectivity ( Fig. 4a) . Likewise, among the 115 infectivitydefective mutants, the vast majority (89 or 77%) showed a normal rate of a b A r t i c l e s proliferation in vitro (Supplementary Table 5 ). The simplest inter pretation of these results is that the requirements for proliferation in vitro are likely to differ substantially from those required for growth in the host. For example, nutrient limitation in the host plus direct attack by the immune system may result in very long doubling times in vivo, rendering irrelevant many of the differences that we observed under optimal conditions in vitro. At a minimum, these results invalidate the common assumption that poor growth in vitro necessarily correlates with decreased virulence.
A Venn diagram summarizing the results of the three systematic screens is presented in Figure 4b . Overall, approximately onethird of the mutants in the library showed a defect in at least one screen. The majority had defects in a single phenotype.
Analysis of mutants predicted to affect glycolipid biosynthesis
Notwithstanding the previous arguments, we focused on infectivity defective mutants with normal colony morphology and normal proliferation in vitro ( Table 2) , hypothesizing that mutants with these characteristics would be most likely to reveal pathways used exclusively for virulence. Among the mutants meeting these criteria, two caught our attention because their mutations were predicted to affect proteins involved in the synthesis of sphingolipids-a class of molecules not previously associated with C. albicans virulence. Orf19.4831 was homologous to known sphingolipid methyltransferases/cyclopropane synthases, and Het1 was homo logous to known sphingolipid transfer proteins. Inspection of mutants with less consistent infectivity defects revealed two additional muta tions affecting proteins that could be ordered with Orf19.4831 and Het1 into a hypothetical biosynthetic pathway for glucosylceramide ( Fig. 5a) . Hsx11 was previously shown to possess sphingolipid glu cosyltransferase activity 28 , and Orf19.260 was homologous to known sphingolipid desaturases.
To experimentally determine whether hsx11, orf19.260 (also called sld1), orf19.4831 and het1 truly defined a glucosylceramide biosyn thetic pathway in C. albicans, we compared membrane lipids from the four mutants and the wildtype strain. Crude lipid fractions prepared from equal masses of cells were resolved using thin layer chromatography (TLC), and glucosylceramide was visualized with anthrone reagent (Fig. 5b) ; soybean glucosylceramide served as a mobility marker (lanes 1 and 2) . The wildtype strain synthesized a product that comigrated with bona fide glucosylceramide (lane 3). By comparison, hsx11 and orf19.260 produced substantially less comi grating product (lanes 4 and 5), orf19.4831 had only a mild decrease (lane 6), and het1 produced as much comigrating product as the wild type (lane 7).
TLC cannot resolve mature glucosylceramide from the preceding two intermediates (Fig. 5a) . Therefore, to determine the identities of the comigrating lipids, we used mass spectrometry. After a further purification step, we resolved lipids from wildtype, hsx11, orf19.260, orf19.4831 and hsx11 strains by TLC, recovered species migrating at the position of mature glucosylceramide and subjected the lipids to matrixassisted laser desorption/ionization-time of flight (MALDI TOF) mass spectrometry. Soybean glucosylceramide was analyzed as a positive control and showed its expected molecular weight (736 for the sodium salt, Fig. 5c ). Wildtype C. albicans produced a pro duct consistent with mature fungal glucosylceramide (778 molecular weight for sodium salt ; Fig. 5d ). The hsx11 mutant produced no product (Fig. 5e) , which was expected, as an intermediate lacking the glucose moiety would not comigrate by TLC. orf19.260 and orf19.4831 accumulated products of molecular weights 766 and 764, respectively ( Fig. 5f,g) ; these are the weights of the sodium salts of the final two intermediates in Figure 5a and indicate that, consistent with our model, Orf19.260 and Orf19.4831 mediate sphingolipid C8 desaturation and C9 methylation reactions, respectively. het1 accumulated a product consistent with mature glucosylceramide (Fig. 5h) ; this mutation affects a predicted sphingolipid transfer protein expected to alter the localization but not synthesis of gluco sylceramide. Together, these results confirm both the biosynthetic pathway of Figure 5a and our assignments of the genes responsible for each step. 
A r t i c l e s
Glucosylceramide is required for virulence
We next tested the virulence of mutants affecting the glucosyl ceramide pathway in single (as opposed to pooled) infections of BALB/c mice. Ten mice were infected with each mutant or wildtype C. albicans, and time to illness was monitored. hsx11, orf19.260 and het1 had significant virulence defects (Fig. 6a,b) , whereas orf19.4831 showed a trend toward reduced virulence that fell outside our significance threshold of 0.05 (Fig. 6a) . To establish whether deletion of the target genes was responsible for these pheno types, we constructed 'addback' strains into which one copy of the wildtype gene was restored. When mice were coinfected with each mutant and its cognate gene addback strain, the addback strain had superior fitness in each case (Fig. 6c-f) . The observa tion that ORF19.4831 complemented the infectivity defect of the orf19.4831 mutant supports our conclusion above that this mutant is mildly attenuated for virulence. These results establish gluco sylceramide biosynthesis as a novel and important determinant of C. albicans virulence. The C. neoformans homolog of hsx11 is also required for virulence in a murine model, but this mutant has an in vitro growth defect at neutral or alkaline pH 29 . We assessed the growth of the C. albicans glucosylceramide pathway mutants on solid laboratory media buffered to pH 7, 7.5, 8, 9 or 10, and found no differences from the wildtype strain (Supplementary Fig. 1) . Therefore, in contrast to C. neoformans, C. albicans glucosylceramide probably mediates virulence through a mechanism other than facilitating growth at mammalian pH.
DISCUSSION
Candida albicans is the most common fungal pathogen of humans, yet progress in under standing its virulence program has been difficult. Its diploid genome, chromosomal instability and incomplete sexual cycle have made genetic approaches especially chal lenging. In this study, we describe the con struction and analysis of homozygous gene deletion mutants that encompass 674 genes. The library contains at least two independent isolates affecting each gene of interest and was created without the use of URA3-an auxo trophic marker that has clouded the inter pretation of most of the previously described mutants in this field. The knockouts in our collection of ~3,000 strains cover ~11% of the C. albicans genome, including genes predicted to affect a wide range of cellular processes, as well as ones whose functions are completely unknown. We detected no aneu ploidy in a survey of 12 mutants using a quan titative PCR assay (six with infectivity defects and six without; Supplementary Table 7) ; however, because aneuploidy can occur dur ing strain construction 17 , we recommend the use of complementation tests for mutants of special interest. Below, we summarize insights gained from systematic screens of the library for (i) host (kidney) colonization, (ii) the yeasttohypha transition and (iii) rate of proliferation in vitro.
Prior to this work, fewer than 200 C. albicans mutants had been tested for virulence in the mouse model of disseminated disease 3 , and there was a nearperfect correlation between mutants with virulence defects and those affecting the yeasttohypha transition (Fig. 1a) . This correlation was based on myriad studies of individual gene disruption mutants that had been created in different laboratories, using different C. albicans strain backgrounds, and tested in different, nonstandardized assays for virulence and morphogenesis. An exception is an infectivity study of a large number of C. albicans mutants created by disrupting one copy of each target gene and placing the other allele under con trol of a repressible promoter 30 . In this case, however, the identities of the disrupted genes were not revealed, the collection was not made freely available, and effects of the mutations on morphogenesis were not reported.
Using our library, we were able to directly compare the results of a standardized screen for infectivity to those for morphogenesis and proliferation in vitro, resulting in several general conclusions. First, across the mutant library, defects in the three properties were relatively common. Approximately 17% of mutants showed reproducible defects in infectivity, 21% of mutants had abnormal morphology, and 10% of mutants were defective for proliferation (Supplementary Table 5 ). The proportion of mutants with infectivity defects was somewhat higher than that reported in signaturetagged mutagenesis screens of bacterial pathogens [21] [22] [23] and far lower than the >80% rate of virulencedefective mutants reported in the C. albicans literature 3 . Second, infectivity defective mutants had a higherthanaverage rate of morphology abnormalities (43% had M scores of 2 or more), and morphogenesis defective mutants were similarly enriched for infectivity defects (40% The glucosylceramide pathway is required for virulence. As described in the text, BALB/c mice were infected with wild-type C. albicans or one of the glucosylceramide pathway mutants, and time to illness was monitored. *Significant difference from wild type by the logrank test; P = 0.0020 for hsx11, P < 0.0001 for orf19.260, P > 0.05 for orf19.4831 and P = 0.032 for het1. (c-f) Wild-type genes restore competitive fitness to the glucosylceramide pathway mutants. Two-strain infectivity assays were performed comparing each mutant to a gene add-back strain in five BALB/c mice. Shown are the R/I values of each strain in individual mice (black dots), the median R/I value (black line) and the P value of the observed differences.
by the Boolian test), supporting the welldescribed crucial role of the yeasttohypha transition in virulence. Finally, our unexpected discov ery that a large group of mutants had substantial defects in infectivity without associated defects in morphogenesis or proliferation in vitro suggests that the process of virulence can be teased apart from the complex morphogenetic program, thereby providing a strategy for identifying discrete effectors of virulence. We tested the ability of our data set to predict novel virulence effectors by focusing on four mutants with specific defects in infectivity but not in morphogenesis or proliferation. Using biochemical methods and mass spectrometry, we demonstrated that Hsx11, Orf19.260 and Orf19.4831 mediate sequential steps in the biosynthesis of fungalspecific glucosyl ceramide (Fig. 5) . Given its homology to lipid transfer proteins, Het1 probably localizes the final product. Hsx11 is already known to possess glucosyltransferase activity 28 , and recently Orf19.260 (also known as Sld1) was independently shown to have sphingolipid desaturase activ ity 31 , consistent with our findings. In twostrain infectivity experiments, all four mutants showed defects in colonizing host kidneys that were com plemented by restoration of the wildtype genes; hsx11, orf19.260 and het1 were also considerably less virulent in classical monotypic infections ( Fig. 6) . Thus, the glucosylceramide biosynthetic pathway is crucial for causing disease as well as for proliferation in the kidney. Not all fungi retain this pathway; for example, S. cerevisiae and S. pombe lack all four genes involved in glucosylceramide synthesis and (proposed) localization. Although several small molecules have previously been associated with virulence of C. albicans 10, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , glucosylceramide is the first such virulence effector found to act independently of the yeasttohypha transition.
C. albicans is unique in being both a normal human fungal commen sal and the most common cause of serious fungal disease. As exempli fied by the glucosylceramide pathway, our identification of 46 genes whose disruption leads to reproducible defects in infectivity in the host but to no observable changes in morphogenesis or proliferation in vitro ( Table 2 ) offers opportunities for understanding the relationship between C. albicans and the mammalian host. The knockout collection should also facilitate investigations of other clinically relevant aspects of C. albicans biology. For example, little is known regarding how C. albicans (or any other organism) functions as a commensal or how the determinants of superficial epithelial infections differ from those required for invasive, dis seminated infections. The development of experimental models of these broader aspects of Candida biology, coupled with the genetic resource and strategies described here, promise new insights into the biology of this important human pathogen. 43 that Orf19.4831 has C9-methyltransferase activity; they name the gene MTS1.
Note added in proof: Another group has independently demonstrated
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Accession codes.
Homozygous disruption mutants will be deposited with the Fungal Genetics Stock Center.
Infectivity screen. Procedures involving animals were approved by the UCSF Institutional Animal Care and Use Committee. Overnight cultures of 48 C. albicans mutants and the isogenic wildtype reference strain QMY23 (ref. 44 ; Supplementary Table 9 ) were diluted 1:20 into fresh YEPD medium and incubated for ~4 h at 30 °C. The logphase cultures were pooled and washed twice with sterile normal saline, and ~1.1 × 10 6 colonyforming units (CFUs) were injected by tail vein into 18 to 20g female BALB/c mice. The inoculum was also plated onto Sabouraud medium (with ampicillin 50 μg/ml, gentamicin 15 μg/ml) and incubated at 30 °C. Mice were monitored closely and euthanized when morbid (defined as weight loss >15%, hunched pos ture, reduced activity). C. albicans was recovered by plating homogenates of mouse kidneys onto Sabouraud with ampicillin and gentamicin (antibiotics were included to suppress contaminating bacteria) and incubating them at 30 °C. Genomic DNA was prepared from yeast scraped off the plates 45 .
Abundance of individual mutants in each pool was determined using real time PCR and primers specific to each signature tag; the second, common primer hybridized to C. dubliniensis HIS1. Reactions included 200 ng of genomic DNA, 2 μM of each primer, 2 mM MgCl 2 , 50 mM KCl, 10 mM Tris 8.3, 0.075× SYBR green (Sigma) and 2 units Taq polymerase. Wildtype C. albicans was quantified using the C. dubliniensis HIS1 primer and primer SNO183 (which hybridizes upstream of LEU2, where C. dubliniensis HIS1 is integrated in this strain). Cycling was performed in an Opticon device (Bio Rad) using the following parameters: 92 °C for 6 min; followed by 40 cycles of 92 °C for 30 s, 52 °C for 45 s, 72 °C for 1 min; and finally 72 °C for 10 min.
Threshold cycle (C T ) values were converted to a linear scale by the following equation: linear value = 2 −C T . Experiments comparing 48 strains resulted in 48 values for the inoculum (I) and another 48 for the recovered pool (R raw ). R raw values were multiplied by median(I)/median(R raw ) to generate normalized R values. Finally, R/I was calculated for each mutant and the wildtype strain; these are presented in Supplementary Tables 10 and 11 . Please see "Statistical analysis", below, for an explanation of statistical methods. Plots and calcula tions were based on mediancentered data.
We used two methods to determine which mutants had significant infectiv ity defects. First, the ttest was used to compare the log 2 (R/I) values of mutants to those of the wildtype data set, using a significance threshold of P < 7.4 × 10 −5 (that is, P < 0.05, corrected for 674 comparisons) to identify mutants that were significantly different from the wild type. The ttest captured all of the infectivity mutants that were obviously depleted in Supplementary  Figure 2a (for example, mutants 7, 9, 23, 29, 39 and 47) and had a very low false discovery rate, estimated at <0.04%. However, close inspection of the data revealed that this test-based on the average log 2 (R/I) of each mutant-missed a class of mutants that had a mix of aberrant phenotypes. Certain mutants (for example, mutants 6, 17, 30, 31 and 41 in Supplementary Fig. 2a) were alternately increased or decreased in kidneys of different hosts, such that the mean log 2 (R/I) ratios were normal even though individual log 2 (R/I) ratios were well outside the mean. This phenomenon is reflected by mutants with high s.d. around the mean in Supplementary Figure 2b and may reflect the presence of multiple fitness deficits that are manifested stochastically in dif ferent infected mice. To include candidates with this phenotype, we devised a Boolean test for aberrant infectivity, defined as having a preponderance (>70%) of R/I measurements that are abnormally high, low or both (<0.7, >2). When applied to 10 6 random sets of six values from the wildtype data set, the false discovery rate of this test was 1.3%.
We compared the ability of the ttest with that of the Boolean test to dis criminate among 57 previously published C. albicans mutants-all previously tested in a mouse tail vein model of disseminated disease-that were included in our library. We note that the published mutants are not a bona fide gold standard for assessing virulence because most were constructed using URA3, and ~30% of reported virulence defects are thought to result from deficient URA3 expression rather than deletion of the target genes 9 . Despite these caveats, the Boolean test showed superior sensitivity and specificity, prop erly identifying 21 of 47 mutants previously reported as virulencedefective ( Supplementary Fig. 2a and Supplementary Table 12 ) and only one of ten mutants previously reported as competent for virulence (in GPA2 (ref. 46); Supplementary Table 12 ). The Boolean method also captured all four virulencedefective mutants that had been constructed without the use of URA3 (refs. [47] [48] [49] [50] . Results of both statistical tests are presented in Supplementary Table 5 . Table 9 ) were plated onto Spider agar at a density of 5-10 CFUs per plate. Colonies were photographed after 7 and 14 d of incubation at 30 °C. Morphology scores were based on colony appearance at 14 d, with consideration of appearance at 7 d in questionable cases.
Morphogenesis screen. Mutants and wildtype reference strain SN250 (Supplementary
Initial assignments were based on the first isolate of every mutant in the library. The center and periphery were scored separately on a scale from −3 (fewer central wrinkles or fewer peripheral filaments) to +3 (increased central wrinkles or peripheral filaments); wildtype morphology was defined as 0. Scoring was blind in that the mutants were numerically coded. One to three additional isolates (depending on availability) of mutants with abnormal phenotypes were analyzed by a different investigator. If an additional isolate had wildtype morphology, the mutant was scored as wildtype (with the presumption that the isolate with abnormal morphology had acquired an additional mutation). Three mutants showed inconsistent abnormal mor phologies and were scored as 'IC'; 18 mutants had severe growth defects on Spider and were not scored.
Proliferation screen. Two isolates of every mutant and the wildtype reference strain QMY23 ( Supplementary Table 9 ) were diluted 1:30 into liquid synthetic complete medium in 96well optically clear plates (Nunc) and incubated with shaking at 37 °C. Absorbance at 600nm wavelength was monitored every 60-90 min for ~10 h with a plate reader (Molecular Devices). Doubling times were calculated from the peak rate of growth between any two time points, and the average of the doubling times of the two isolates was reported.
Virulence analysis. Cultures of SN285 (hsx11, also called orf19.4592), SN255 (orf19.260), SN290 (orf19.4831), SN297 (het1, also called orf19.6327) and the isogenic reference strain SN250 (wild type) were prepared in liquid synthetic complete medium and grown for 2 d at room temperature. Mid to late log phase cells were washed twice with sterile normal saline and counted using a hemacytometer. We used ~4.5 × 10 5 CFUs of each strain to infect ten female 18 to 20g BALB/c mice by tail vein injection. Mice were monitored twice daily and euthanized when morbid, as judged by criteria described above.
Complementation analysis. Plasmids for complementation were constructed using PCR and homologous recombination in S. cerevisiae 51 The plasmids (pSN103, HSX11; pSN104, orf19.260; pSN101, orf19.4831; and pSN102, HET1) were engineered to sandwich a wildtype copy of each test gene and C. dubliniensis ARG4 between sequences upstream and downstream of the C. albicans LEU2 gene. Inserts were sequenced to verify the absence of muta tions. Disruption fragments were liberated by digestion with PmeI and intro duced into the appropriate mutants (SN285, hsx11; SN255, orf19.260; SN290, orf19.4831; and SN297, het1; Supplementary Table 9 ). An additional plasmid (pSN105) was created with just the C. dubliniensis ARG4 gene and C. albicans LEU2 flanking sequences; this was used to create auxotrophic markermatched versions of the homozygous deletion mutants. Strain designations appear in Supplementary Table 9 .
We performed twostrain infectivity experiments by infecting female 18 to 20g BALB/c mice by tail vein with ~8 × 10 5 CFUs of a 1:1 pool of each mutant and its gene addback comparitor. Five mice were infected with each pool, and the abundance of strains in the inoculum compared with the infected kidneys was determined by realtime PCR. Standard curves were created using dilu tions of genomic DNA from individual strains.
Lipid extraction and mass spectrometry. We incubated 100ml cultures (in YEPD) of SN425 (wild type), SN442 (hsx11), SN444 (orf19.260), SN446 (orf19.4831) and SN448 (het1) with shaking at 30 °C overnight. Cell pel lets were frozen in liquid nitrogen and lyophilized overnight. We extracted 10 mg of each lyophilized cell pellet for 48 h with chloroform/methanol (2:1, vol/vol). The extract was mixed with 0.2 volumes of 0.34% (wt/vol) MgCl 2 . The aqueous layer was discarded and the organic phase mixed with 5 ml of 2 N KCl/methanol (4:1, vol/vol). The aqueous layer was discarded, and the organic phase was washed six times with 5 ml artificial upper phase (chloroform/methanol/water, 3:48:47, vol/vol/vol). The organic phase was dried under N 2 vapor and then dissolved in 500 μl CHCl3/methanol (2:1, vol/vol). We then applied 30 μl of each preparation to a silica gel 60 high performance TLC plate (Whatman); soybean glucosylceramide (Polar Lipids) was included as a mobility marker, and chloroform/methanol (90:25, vol/vol) was the mobile phase. Glucosylceramide was visualized with anthrone reagent (in concentrated H 2 SO 4 ) and baking.
For mass spectrometry, 450 μl of each lipid preparation was resolved on silica gel 60 plates with divided lanes (J.T. Baker). For each test sample, the region of TLC resin that aligned with soybean glucosylceramide was scraped into 5 ml CHCl 3 /methanol (2:1). Samples were dried under N 2 vapor, solu bilized in 5 ml of 0.1 N NaOH/methanol, then incubated at 55 °C for 1 h. Mixtures were acidified with 1 ml of 1 N HCl/methanol, mixed with five drops of water and 5 ml hexane, and centrifuged. The lower phase was removed and evaporated under N 2 vapor, and the lipid residue dissolved in 2 ml theoretical lower phase (chloroform/methanol/water 86:14:1). We added 8 ml of theo retical upper phase (chloroform/methanol/water 3:48:47) to create a Folch partition. After centrifugation, the lower phase was recovered, evaporated to dryness and solubilized in 200 μl chloroform/methanol (2:1, vol/vol). Samples were mixed 1:1 with 10 mg/ml 2,5dihydroxybenzoic acid (in chloroform/ methanol 2:1, vol/vol) and assessed with a VoyagerDE MALDITOF mass spectrometer (Applied Biosystems) in reflector mode.
Statistical analysis. The hypergeometric distribution was used to evaluate the significance of associations of virulence with morphogenesis among published mutants, of virulence with kidney burden among published mutants, of previ ously published virulence defects with infectivity defects in our reconstructed mutants, and of all combinations of defects in infectivity, morphogenesis and proliferation in our screens. P < 0.05 was considered significant.
The ttest (twotailed, comparison of unpaired samples) was used to evaluate the significance of the following differences: (i) log 2 (R/I) values of mutants in the infec tivity screen versus the wildtype reference strain, with P < 0.05/674 considered significant (Bonferroni correction for multiple comparisons); and (ii) log 2 (R/I) values of the glucosylceramide mutants and their cognate gene addback strains in the paired infectivity experiments, with P < 0.05 considered significant.
The logrank test was used to compare the timetoillness curves of mice infected with wildtype C. albicans versus mutants in the glucosylceramide pathway; P < 0.05 was considered significant.
False discovery rates for the ttest and the Boolean methods of identifying infectivity mutants were determined by applying these tests to 1,000 random sets of six values from the wildtype data set 1,000 times and calculating the median percentage identified as positive.
URL. Candida Genome Database, http://www.candidagenome.org/.
